IN SILICO HEAD-TO-HEAD COMPARISON OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC IN TYPE 1 DIABETES

被引：0

作者：

Visentin, R. ^{[1
]}

Schiavon, M. ^{[1
]}

Giegerich, C. ^{[2
]}

Sieber, J. ^{[2
]}

Man, C. Dalla ^{[1
]}

Cobelli, C. ^{[1
]}

Klabunde, T. ^{[2
]}

机构：

[1] Univ Padua, Dept Informat Engn, Padua, Italy

[2] Sanofi Aventis Deutschland GmbH, Frankfurt, Germany

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2018年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

037

引用

页码：A18 / A18

页数：1

共 50 条

[41] Response to insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
Yamabe, Mizuho
JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (06) : 1597 - 1598
[42] COMPARATIVE COST AND SAVING ANALYSIS OF INSULIN GLARGINE-300U/ML (GLA-300) VS INSULIN DEGLUDEC 100 U/ML IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS BASED ON THE BRIGHT
Safia, M.
Hachelaf, Z.
Aissaoui, A.
Mahieu, A.
Abdul, Jabbar O. A.
VALUE IN HEALTH, 2024, 27 (12) : S123 - S123
[43] Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus
Linari, Guido
Fleeman, Linda
Gilor, Chen
Giacomelli, Lucia
Fracassi, Federico
JOURNAL OF FELINE MEDICINE AND SURGERY, 2022, 24 (02) : 168 - 176
[44] Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial
Bolli, Geremia B.
Cheng, Alice
Charbonnel, Bernard
Aroda, Vanita R.
Westerbacka, Jukka
Bosnyak, Zsolt
Boelle-Le Corfec, Emmanuelle
Rosenstock, Julio
DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1588 - 1593
[45] Similar glycaemic control and less or comparable hypoglycaemia with insulin glargine 300 U/ml vs degludec 100 U/ml in insulin naive type 2 diabetes: the BRIGHT randomised study
Cheng, A.
Rosenstock, J.
Ritzel, R.
Bosnyak, Z.
Devisme, C.
Stella, P.
Cali, A. M. G.
Wang, X.
Frias, J.
Roussel, R.
Bolli, G. B.
DIABETOLOGIA, 2018, 61 : S42 - S42
[46] Lower hypoglycemia rates with Glargine 300 U/mL vs. insulin Degludec 100 U/mL in insulin-naive adults with type 2 diabetes - The BRIGHT Randomized Study
Bolli, Geremia
Scherer, Thomas
Cheng, Alice
Bosnyak, Zsolt
Boelle-Le Corfec, Emmanuelle
Cali, Anna
Wang, Xiangling
Frias, Juan
Roussel, Ronan
Rosenstock, Julio
WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 369 - 369
[47] Comparison of insulin glargine 300 U/mL and insulin degludec using flash glucose monitoring: A randomized cross-over study
Yamabe, Mizuho
Kuroda, Mami
Hirosawa, Yasuyo
Kamino, Hiromi
Ohno, Haruya
Yoneda, Masayasu
JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 352 - 357
[48] A Comparison of Insulin Glargine U300 and Insulin Degludec around Spontaneous Exercise Sessions in People with Type 1 Diabetes-The ULTRAFLEXI-1 Study
Moser, Othmar
Mueller, Alexander
Aberer, Felix
Aziz, Faisal
Kojzar, Harald
Sourij, Caren
Obermayer, Anna M.
Abbas, Farah M.
Birnbaumer, Philipp
Eckstein, Max L.
Honger, Lukas
Lenz, Jacqueline
Mursic, Ines
Sternad, Christoph
Zanker, Matthias
Ziko, Haris
Pferschy, Peter N.
Tripolt, Norbert J.
Sourij, Harald
DIABETES, 2022, 71
[49] Effectiveness and Safety of Insulin Glargine 300 U/ml in Comparison with Insulin Degludec 100 U/ml Evaluated with Continuous Glucose Monitoring in Adults with Type 1 Diabetes and Suboptimal Glycemic Control in Routine Clinical Practice: The OneCARE Study
Ignacio Conget
Miguel Ángel Mangas
Cristóbal Morales
Juan Caro
Margarita Giménez
Mireia Borrell
Elías Delgado
Diabetes Therapy, 2021, 12 : 2993 - 3009
[50] Effectiveness and Safety of Insulin Glargine 300 U/ml in Comparison with Insulin Degludec 100 U/ml Evaluated with Continuous Glucose Monitoring in Adults with Type 1 Diabetes and Suboptimal Glycemic Control in Routine Clinical Practice: The OneCARE Study
Conget, Ignacio
Angel Mangas, Miguel
Morales, Cristobal
Caro, Juan
Gimenez, Margarita
Borrell, Mireia
Delgado, Elias
DIABETES THERAPY, 2021, 12 (11) : 2993 - 3009

← 1 2 3 4 5 →